ECCO 12 - the European Cancer Conference

ECCO 12 the European Cancer Conference
Sunday 21 September Thursday 25 September 2003
Bella Center A/S, Center Boulevard, Copenhagen, Denmark

Join 10,000 international cancer experts at ECCO 12 Europe's premier cancer conference: the only forum in Europe covering the entire spectrum of research, treatment and care for all types of tumours. An opportunity to hear the latest research findings and sit in on debates and discussions on controversies in cancer.

  • Registration free for all media providing bona fide press credentials
  • All sessions open to journalists
  • A fully equipped media centre with computers and free phone and internet facilities
  • Daily news briefings

    News briefing programme (subject to confirmation):

    Sunday 21 September 17.00hrs:

    • Join EU and FECS' representatives for a Round Table discussion on R and D challenges in cancer and the growing problem of unequal access to cancer care in Europe. Your chance to quiz the experts.

    Monday 22 September 13.00hrs:

    • Dr Michael Stratton: Cancer genes - a realistic target for drug development?
    • Dr Nicolaj Andreassen: Tailoring radiotherapy - new findings predict sensitivity to radiation damage
    • Prof. Richard Peto: Hormonal treatment in prostate & breast cancer latest findings on increasing 10-year survival

    Tuesday 23 September 13.00hrs

    • Prof Anthony Howell: Update on ATAC [Arimidex, Tamoxifen Alone or in Combination] trial
    • Prof Peter Ravdin: First head-to-head paclixtaxel v docetaxel trial in breast cancer world-first presentation of findings
    • Lynn Faulds-Wood & Kathy Redmond launch of the European Cancer Patient Coalition (ECPC) Europe's first patient advocacy group for all types of cancer

    Wednesday 24 September 13.00hrs

    • Prof Jens Overgaard: Shorter radiotherapy helps head and neck can

    Contact: Margaret Willson
    Federation of European Cancer Societies

    Page: 1 2

    Related biology news :

    1. European common frog found to use novel mating strategy
    2. Zoonotic diseases - European scientists unite to fight diseases
    3. Second call for proposals for the European Young Investigator Award
    4. Common call for action on European Research Council (ERC)
    5. EURYI Award given for the first time to 25 young European researchers
    6. European researchers tackle mitosis
    7. Key principles for the foundation of a European Research Council (ERC)
    8. EC boosts European electron microscopy research
    9. Plants for the future: A European vision for plant biotechnology towards 2025
    10. European Commission approves Herceptin + Taxotere as 1st-line therapy in HER2-positive breast cancer
    11. Limited climate tracking in European trees despite 10,000 years of postglacial warmth

  • Post Your Comments:

    (Date:1/14/2019)... ... January 14, 2019 , ... CellMax ... cancer cells in blood, will present new findings at the ASCO Gastrointestinal Cancer ... colorectal cancer. The results from this study show CellMax Life’s blood test, based ...
    (Date:1/10/2019)... (PRWEB) , ... January 09, 2019 , ... Dr. Beanlands ... Heart Institute in Ottawa, Ontario, Canada. He is also Director of its National ... of Medicine, in the Department of Radiology, and in the Department of Cellular and ...
    (Date:1/10/2019)... ... 2019 , ... A major goal for pharmaceutical companies has ... significantly more expensive in vivo studies in order to reduce costs and improve ... researchers have begun to adopt 3D cell culture models which have been shown ...
    Breaking Biology News(10 mins):
    (Date:12/20/2018)... ... December 20, 2018 , ... New Year’s brings reflection ... changes in regulations in the European Union (EU) on the horizon, Jim Kasic, president ... , “The transition to the EU Medical Device Regulation (MDR), digital health, and big ...
    (Date:12/18/2018)... ... December 18, 2018 , ... Patients with early stages of breast cancer who ... post-treatment versus whole breast irradiation, a new study suggests. , Patients with early stage ... irradiation after removal of the cancerous tumor because there is a 30 to 40 ...
    (Date:12/13/2018)... ... December 13, 2018 , ... Microbial Discovery Group LLC (MDG) ... been part of their strategic plan and an important milestone in increasing their ... opportunities for MDG within the $44 Billion human probiotic market. This plan is ...
    (Date:12/5/2018)... (PRWEB) , ... December 04, ... ... an established North American full-service contract research organization (CRO), announced the acquisition ... transaction significantly strengthens ARG’s reach and experience in the management of clinical ...
    Breaking Biology Technology:
    Cached News: